Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemiaRenato Bassan, Alessandro Rambaldi, Orietta Spinelli et al.|Blood Cancer Journal|2014Cited by 63
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Alessandro Rambaldi, Cristina Boschini et al.|Blood Advances|2019Cited by 33
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06Chiara Caprioli, Alessandro Rambaldi, Federico Lussana et al.|Haematologica|2020Cited by 22
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trialGiacomo Gianfaldoni, Renato Bassan, Francesco Mannelli et al.|Blood Advances|2020Cited by 15
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)Silvia Salmoiraghi, Orietta Spinelli, Roberta Cavagna et al.|Cancers|2020Cited by 10